It is a pharma private limited company based in Raipur, Chattisgarh, India, established in 2009.
2009 | Raipur, Chattisgarh, India | ActiveLuvis Pharmaceuticals Private Limited, a active private limited company, was established on 04 February 2009 in Raipur, Chattisgarh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232CT2009PTC021036. Registered under ROC Roc Chhattisgarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.67 M.
It upholds a compliant status. Its leadership includes Veena Gupta (Director), Satish Kumar Gupta (Director), Rituparn Gupta (Director). Past directors included Rituparn Gupta. It holds ₹9.51 M open charges and ₹6.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 27/627, Street No. 7 New Shanti Nagar, Raipur, Chattisgarh, 492001.
U24232CT2009PTC021036
021036
04 February 2009
₹1.00 M
₹0.67 M
Roc Chhattisgarh
Unlisted
Active
Explore comprehensive insights into Luvis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veena Gupta | Director | 04 Feb 2009 | Current |
| Satish Kumar Gupta | Director | 12 Mar 2009 | Current |
| Rituparn Gupta | Director | 15 Jan 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 May 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Luvis Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.82% increase. The company also saw a substantial fall in profitability, with a 32.2% decrease in profit. The company's net worth moved up by a moderate rise of 3.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Luvis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,511,000.00
₹6,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2022 | Uco Bank | ₹0.80 M | Open |
| 26 Feb 2014 | Uco Bank | ₹8.71 M | Open |
| 13 Jun 2011 | Bank Of Baroda | ₹4.00 M | Satisfied |
| 17 Jul 2010 | State Bank Of India | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Luvis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Luvis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Luvis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Luvis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Luvis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chhattisgarh. was completed.
The activity A charge with Uco Bank amounted to Rs. 0.80 M with Charge ID 100655500 was registered on 30 Sep 2022. was completed.
A charge with Uco Bank of Rs. 8.71 M registered on 26 Feb 2014 with Charge ID 10480670 was modified on 30 Jun 2022. was recorded as a recent event.
A charge with Uco Bank amounted to Rs. 8.71 M with Charge ID 10480670 was registered on 26 Feb 2014. was recorded as a recent event.
The activity A charge registered on 13 Jun 2011 via Charge ID 10296722 with Bank Of Baroda was fully satisfied on 28 Jan 2014. was completed.
The CIN of Luvis Pharmaceuticals Private Limited is U24232CT2009PTC021036.
Luvis Pharmaceuticals Private Limited is headquartered at 27/627, Street No. 7 New Shanti Nagar, Raipur, Chattisgarh, 492001.
Luvis Pharmaceuticals Private Limited was incorporated on 04 February 2009.
The current directors of Luvis Pharmaceuticals Private Limited are
The primary industry of Luvis Pharmaceuticals Private Limited is Trade.
Luvis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Luvis Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.67 M.
The compliance status of Luvis Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX